A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy
Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma
About this trial
This is an interventional treatment trial for Pancreatic Cancer focused on measuring Robot-assisted pancreaticoduodenectomy, Safety and Efficacy, randomized controlled trial
Eligibility Criteria
Inclusion Criteria: Over 18 years old Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy No distant transfer No significant vascular invasion was received Exclusion Criteria: With tumors of other organs Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery Preoperative adjuvant therapy was given
Sites / Locations
Arms of the Study
Arm 1
Other
Robot-assisted Pancreaticoduodenectomy
By performing pancreaticoduodenectomy on the subject using the latest generation Da Vinci robotic surgical system and assisted by another surgeon for the entire procedure